The CLEC2D-KLRB1 interaction has been noted between myeloid and NK cells in human neuroblastoma and between tumor and CD8 T cells in human rhabdomyosarcoma (23, 24), pointing to the presence of immunosuppressive networks in the liver. Here, CLEC2D is linked to neuroblastoma.